↓ Skip to main content

Dove Medical Press

Targeted Treatment of Advanced Endometrial Cancer: Focus on Pembrolizumab

Overview of attention for article published in OncoTargets and therapy, June 2023
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age and source (64th percentile)

Mentioned by

twitter
1 X user

Citations

dimensions_citation
4 Dimensions

Readers on

mendeley
4 Mendeley
Title
Targeted Treatment of Advanced Endometrial Cancer: Focus on Pembrolizumab
Published in
OncoTargets and therapy, June 2023
DOI 10.2147/ott.s368050
Pubmed ID
Authors

Nathan El-ghazzi, Xavier Durando, Alexia Giro, Tressie Herrmann

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 4 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 4 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 1 25%
Unknown 3 75%
Readers by discipline Count As %
Medicine and Dentistry 1 25%
Unknown 3 75%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 June 2023.
All research outputs
#17,874,772
of 26,173,059 outputs
Outputs from OncoTargets and therapy
#1,161
of 3,020 outputs
Outputs of similar age
#231,088
of 397,620 outputs
Outputs of similar age from OncoTargets and therapy
#4
of 14 outputs
Altmetric has tracked 26,173,059 research outputs across all sources so far. This one is in the 21st percentile – i.e., 21% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,020 research outputs from this source. They receive a mean Attention Score of 3.1. This one has gotten more attention than average, scoring higher than 51% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 397,620 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 29th percentile – i.e., 29% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 14 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 64% of its contemporaries.